Staphylocoagulase as a hemostatic agent.
作者信息
Mojovic B, Mojovic N, Tager M, Drummond M C
出版信息
Yale J Biol Med. 1969 Aug;42(1):11-20.
Abstract
摘要
相似文献
1
Staphylocoagulase as a hemostatic agent.葡萄球菌凝固酶作为一种止血剂。
Yale J Biol Med. 1969 Aug;42(1):11-20.
2
[Staphylocoagulase and staphylothrombin].[葡萄球菌凝固酶和葡萄球菌凝血酶]
Postepy Hig Med Dosw. 1977 Jan-Feb;31(1):17-31.
3
[The action of staphylocoagulase in blood coagulation].
Ned Tijdschr Geneeskd. 1974 Aug 17;118(33):1268-71.
4
Purification and properties of staphylocoagulase.葡萄球菌凝固酶的纯化及性质
Biochim Biophys Acta. 1975 Jan 30;379(1):164-71. doi: 10.1016/0005-2795(75)90018-5.
5
Formation and properties of fibrin clots resulting from staphylocoagulase (SC) action.由葡萄球菌凝固酶（SC）作用产生的纤维蛋白凝块的形成及特性。
Thromb Diath Haemorrh. 1967 Dec 31;18(3-4):475-86.
6
[Reptilase and thrombin-coagulase times in full-term newborns and in the 1st years of life].[足月儿及出生后第一年婴儿的爬虫酶及凝血酶-凝固酶时间]
Boll Soc Ital Biol Sper. 1975 Oct 15;51(19):1229-33.
7
[Staphylococcal coagulase liberation from toxic-enzyme complex components].[从毒性酶复合成分中释放葡萄球菌凝固酶]
Zh Mikrobiol Epidemiol Immunobiol. 1978 Aug(8):123-6.
8
Evaluation of hemostatic effects of Ankaferd as an alternative medicine.评估安卡非德作为替代药物的止血效果。
Altern Med Rev. 2010 Dec;15(4):329-36.
9
Comparative evaluation of systemic coagulants in dogs.犬类全身凝血剂的比较评估
Arzneimittelforschung. 1967 Dec;17(12):1573-4.
10
In vivo and in vitro hemostatic activity of Chromolaena odorata leaf extract.紫茎泽兰叶提取物的体内和体外止血活性。
Pharm Biol. 2012 Sep;50(9):1073-7. doi: 10.3109/13880209.2012.656849.
引用本文的文献
1
The Evolution of Safe and Effective Coaguligands for Vascular Targeting and Precision Thrombosis of Solid Tumors and Vascular Malformations.用于实体肿瘤和血管畸形的血管靶向及精准血栓形成的安全有效凝血配体的演变
Biomedicines. 2021 Jul 4;9(7):776. doi: 10.3390/biomedicines9070776.
2
NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth.NGR（天冬酰胺-甘氨酸-精氨酸）靶向递送达玛司他丁至肿瘤血管，抑制肿瘤细胞生长。
Oncogene. 2018 Jul;37(29):3967-3980. doi: 10.1038/s41388-018-0213-4. Epub 2018 Apr 17.
3
RGD delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice.RGD 递呈截短型凝固酶至肿瘤血管，引发局部血栓形成，导致小鼠肿瘤梗死。
Sci Rep. 2017 Aug 15;7(1):8126. doi: 10.1038/s41598-017-05326-9.
4
5
Release of beta-lysin from platelets by thrombin and by a factor produced in heparinized blood.凝血酶和肝素化血液中产生的一种因子可促使血小板释放β-溶素。
Infect Immun. 1974 Jan;9(1):179-86. doi: 10.1128/iai.9.1.179-186.1974.
本文引用的文献
1
SPECIFIC COAGULASES OF STAPHYLOCOCCUS AUREUS.金黄色葡萄球菌的特异性凝固酶。
J Exp Med. 1950 Feb 28;91(3):295-307. doi: 10.1084/jem.91.3.295.
2
Concentration, partial purification, properties, and nature of staphylocoagulase.葡萄球菌凝固酶的浓度、部分纯化、性质及本质
Yale J Biol Med. 1948 May;20(5):487-501.
3
The experimental production of antibodies to staphylocoagulase.针对葡萄球菌凝固酶抗体的实验性制备。
J Immunol. 1948 Dec;60(4):475-85.
4
Staphylococcal coagulase; mode of action and antigenicity.葡萄球菌凝固酶；作用方式与抗原性。
J Gen Microbiol. 1952 Feb;6(1-2):95-107. doi: 10.1099/00221287-6-1-2-95.
5
Immunisation against experimental staphylococcal infection with coagulase-rich preparations.用富含凝固酶的制剂对实验性葡萄球菌感染进行免疫接种。
Lancet. 1962 Jun 23;1(7243):1315-8. doi: 10.1016/s0140-6736(62)92420-0.
6
Permanent cannulation of aorta and vena cava in rats and ground squirrels.大鼠和地松鼠主动脉及腔静脉的永久性插管
J Appl Physiol. 1960 Jul;15:727-8. doi: 10.1152/jappl.1960.15.4.727.
7
Purification of staphylococcal coagulase.葡萄球菌凝固酶的纯化
Biochim Biophys Acta. 1960 Jun 3;40:518-22. doi: 10.1016/0006-3002(60)91392-5.
8
INTRAVASCULAR COAGULATION AND FIBRINOLYSIS BY STAPHYLOCOAGULASE. COMPARISON WITH THROMBIN.葡萄球菌凝固酶介导的血管内凝血与纤维蛋白溶解。与凝血酶的比较。
Thromb Diath Haemorrh. 1965 Jun 15;13:457-69.
9
10
ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID.鞣花酸溶液对Hageman因子的激活作用。
J Lab Clin Med. 1964 Mar;63:359-77.
Zotero 插件